May 13, 2020 / 1:26 AM / 25 days ago

BRIEF-Cansino Biologics Collaborates With National Research Council Of Canada To Advance Clinical Trial For Recombinant Covid-19 Vaccine

May 13 (Reuters) - Cansino Biologics Inc:

* COLLABORATION WITH NATIONAL RESEARCH COUNCIL OF CANADA TO ADVANCE CLINICAL TRIAL FOR RECOMBINANT COVID-19 VACCINE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below